leo80122
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00404196)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Vitamin D receptorAGONIST
VDR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leo80122
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00392067 | Phase 2 | Oct 1, 2006 | Leo Pharma, Uppsala University |
| NCT00404196 | Phase 2 | Oct 1, 2006 | Leo Pharma, University of Nottingham |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leo Pharma | For profit | 2 | 2 | 1 | 2006 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Uppsala University | Academic/Hospital | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1